A detailed history of Allworth Financial LP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 1,497 shares of PACB stock, worth $2,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,497
Previous 79 1794.94%
Holding current value
$2,619
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$1.36 - $3.65 $1,928 - $5,175
1,418 Added 1794.94%
1,497 $2,000
Q1 2024

Apr 25, 2024

SELL
$3.52 - $9.59 $130 - $354
-37 Reduced 31.9%
79 $0
Q4 2023

Jan 24, 2024

SELL
$5.97 - $10.36 $1,223 - $2,123
-205 Reduced 63.86%
116 $1,000
Q4 2022

Jan 13, 2023

BUY
$5.67 - $11.2 $243 - $481
43 Added 15.47%
321 $0
Q2 2022

Jul 13, 2022

BUY
$4.02 - $10.43 $144 - $375
36 Added 14.88%
278 $1,000
Q4 2019

Jan 16, 2020

BUY
$4.6 - $5.57 $1,113 - $1,347
242 New
242 $1,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $393M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.